A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer, Locally
Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (POZITIVE20-1)
Cancer - Lung
Sai-Hong Ignatius Ou
For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email email@example.com.